Chronic bronchopulmonary diseases in children: developmental characteristics and clinical course
https://doi.org/10.36604/1998-5029-2025-96-18-32
Abstract
This lecture summarises long-term clinical observations of children with various forms of chronic non-specific lung diseases (CNLD), which have enabled the author to formulate a concept of dysontogenetic disorders of the bronchopulmonary system arising at both prenatal and postnatal levels. Such disorders develop through biochemical, molecular and cellular changes triggered by a combination of exogenous and endogenous damaging factors – nutrient and essential-trace-element deficiency or imbalance, intrauterine viral infection and environmental exposures – that programme physiological and metabolic reactions from the earliest stages of bronchopulmonary organogenesis through to adult life. This approach opens up possibilities for a scientifically grounded primary prevention of dysontogenetically determined pulmonary pathology in children. The author presents a differential diagnostic algorithm for analyzing recurrent and chronic bronchopulmonary pathology.
Keywords
About the Author
V. K. KozlovRussian Federation
Vladimir K. Kozlov, MD, PhD, DSc (Med.), Professor, Corresponding Member of RAS, Main Staff Scientist
Laboratory of Integral Methods of Bronchopulmonary and Perinatal Pathology Research; Group of Health and Environmental Problems of Mother and Child Health
680022; 49/1 Voronezhskaya Str.; Khabarovsk
References
1. Evseeva G.P., Kholodok G.N., Morozova N.V., Suprun E.N., Kozlov V.K., Lazar K.G. [Epidemiology of bronchopulmonary diseases in children and teenagers of Khabarovsk territory]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin of Physiology and Pathology of Respiration 2016; 61:31–35 (in Russian). doi: 10.12737/21436
2. Chuchalin A.G. [Modern classification of clinical forms of bronchopulmonary diseases in children]. Pediatriya. Zhurnal im G.N. Speranskogo 2010; 89(4):6–15 (in Russian).
3. [State Report on the state and Environmental Protection of the Khabarovsk Territory in 2023]. Khabarovsk: Ministerstvo prirodnykh resursov Khabarovskogo kraya; 2024 (in Russian).
4. Suprun S.V., Evseeva G.P., Kudryashova O.S., Kuderova N.I., Lebed’ko O.A. [Ecological and ethnic features of the microelement status of blood in pregnant women of Priamurie]. Mikroelementy v medizhine = Trace elements in medicine 2021; 22(S1):65–66 (in Russian). doi: 10.19112/2413-6174-2021-S1-32
5. Suprun S.V., Kuderova N.I., Evseeva G.P., Lebed’ko O.A. [Comprehensive assessment of the actual nutrition of pregnant women in the Amur region]. Problems of Nutrition 2018; 87(S5):43–44 (in Russian). doi: 10.24411/0042-8833-2018-10127
6. Evseeva G.P. [Microelement status and the relationship of its imbalance with the development of diseases in children : abstract of Doctor’s dergree dissertaion thesis]. Khabarovsk, 2009 (in Russian).
7. Kozlov V.K., Lebedko O.A., Pichugina S.V., Sirotina-Karpova M.S., Evseeva G.P., Gandurov S.G. [Relevant problems of chronic obstructive pulmonary diseases in children]. Clinical Practice in Pediatrics 2019; 14(3):22–31 (in Russian). doi: 10.20953/1817-7646-2019-3-22-31
8. Lebed'ko O.A., Ryzhavskii B.Ya. [Effect of administration of lead nitrate to pregnant rats on the lungs in their offspring]. Bulletin of experimental biology and medicine 2005; 139(6):621–623 (in Russian). doi: 10.1007/s10517-005-0369-0
9. Cheresh P., Kim S.J., Tulasiram S., Kamp D.W. Oxidative stress and pulmonary fibrosis. Boichim. Biophys. Acta. 2013; 1832(7):1028–1040. doi: 10.1016/j.bbadis.2012.11.021
10. Lebed'ko O.A., Ryzhavskiy B.Y., Demidova O.V. [Effect of antioxidant echinochrome A on bleomycin-induced pulmonary fibrosis]. Bulletin of experimental biology and medicine 2015; 159(3):351–354 (in Russian). doi: 10.1007/s10517-015-2960-3
11. Lee I.T., Yang C.M. Role of NADPH oxidase/ROS in proinflammatory mediators-induced airway and pulmonary disease. Biochem. Pharmacol. 2012; 84(5):581–590. doi: 10.1016/j.bcp.2012.05.005
12. Santos-Silva M.A., Pires K.M., Trajano E.T., Martins V., Nesi R.T., Benjamin C.F., Caetano M.S., Sternberg C., Machado M.N., Zin W.A., Valença S.S., Porto L.C. Redox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c mice. Toxicol. Pathol. 2012; 40(5):731–741. doi: 10.1177/0192623312441404
13. Lebedko О.А., Gusyeva О.Е., Коzlov V.К. [Damages of oxidative metabolism in children with chronic bronchoobstructive diseases]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin of Physiology and Pathology of Respiration 2007; 27:12–13 (in Russian).
14. Sarkisov D.S. [Essays on the history of general pathology]. Moscow: Medpraktika; 1998 (in Russian).
15. Kozlov V.K., Tselykh E.D., Evseeva G.P., Suprun S.V. [Actual nutrition, microelementoses and deficiency conditions in children and adolescents]. Vladivostok; 2010 (in Russian). ISBN: 978-5-8044-1126-9.
16. Akinfeev A.A., Ryzhavsky B.Ya., Gandurov S.G. [Morphological characteristics of the alveoli in children with pulmonary hypoplasia]. Dal'nevostochnyy meditsinskiy zhurnal 2004; 2:71–77 (in Russian).
17. [Clinical recommendations «Bronchopulmonary dysplasia»]. Мoskow; 2024 (in Russian).
18. Butler M.G. Imprinting disorders in humans: a review. Curr. Opin. Pediatr. 2020; 32(6):719–729. doi: 10.1097/MOP.0000000000000965
19. Altmae S., Stavreus-Evers A., Ruiz J.R., Laanpere M., Syvanen T., Yngve A., Salumets A., Nilsson T.K. Variations in folate pathway genes are associated with unexplained female infertility. Fertil. Steril. 2010; 94(1):130–137. doi: 10.1016/j.fertnstert.2009.02.025
20. Sugurova A.T., Yashchuk A.G., Tyurina A.A., Yalaev B.I., Kharisova Z.I., Khusainova R.I. [Influence of polymorphism of folate cycle genes in assisted reproductive technologies programs in women with infertility and miscarriage]. Russian Journal of Human Reproduction 2023; 29(1):39–47 (in Russian). doi: 10.17116/repro20232901139
21. Suprun S.V., Larina T.N., Kozlov V.K., Chizhova G.V., Morozova O.N., Kudryashova O.S. [Structure of folate cycle gene polymorphism (MTHFR) in pregnant indigenous and alien women]. Tavricheskiy mediko-biologicheskiy vestnik 2013; 16(2-2):115–118 (in Russian).
22. Gordeeva L.A., Oskorbina O.S., Voronina E.N., Sokolova E.A., Shatalina I.V., Olennikova R.V., Nersesyan S.L., Filipenko M.L., Glushkov A.N. [Association between cytokine gene polymorphisms and recurrent miscarriage]. Medical Immunology (Russia) 2017; 19(5):585–596 (in Russian). doi: 10.15789/1563-0625-2017-5-585-596
23. Zaitseva N.V., Dolgikh O.V., Subbotina A.A., Yaroma A.V. [Polymorphism of the microsomal epoxide hydrolase EPHX1 gene (rs1051740) in often ill children living in the industrial region of Southern Siberia]. Yakut Medical Journal 2023; 3(83):65–67 (in Russian). doi: 10.25789/YMJ.2023.83.16
24. Аkparova A., Abdrakhmanova B., Banerjee N., Bersimbaev R. EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population. Mutat. Res. Genet. Toxicol. Environ Mutagen. 2017; 816-817:1–6. doi: 10.1016/j.mrgentox.2017.02.004
25. Demikova N.S., Lapina A.S., Podolnaya M.A., Putintsev A.N. [The value of genetic analysis in the study of the nature of congenital malformations]. Russian Bulletin of Perinatology and Pediatrics 2020; 65(5):7–11 (in Russian). doi: 10.21508/1027–4065–2020–65–5–7–11
26. Orlova S.V., Kodentsova V.V., Nikitina E.A., Pronina O.E., Prokopenko E.V., Vodolazkaya A.N. [State of nutritional status of woman as one of mechanisms of fetal programming]. Meditsinskiy alfavit = Medical Alphabet 2020; 26:6–11 (in Russian). doi: 10.33667/2078-5631-2020-26-6-11
27. de Boo H.A., Harding J.E. The developmental origins of adult disease (Barker) hypothesis. Aust. N.Z.J. Obstet. Gynaecol. 2006; 46(1):4–14. doi: 10.1111/j.1479-828X.2006.00506.x
28. Meck W.H., Williams C.L. Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci. Biobehav. Rev. 2003; 27(4):385–399. doi: 10.1016/s0149-7634(03)00069-1
29. Vysokogorskiy V.Ye., Kurch N.M. [Metabolic impringting in fetal alcoholic intoxication]. Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences 2014; 34(1):5–9 (in Russian).
30. Matveeva M.V., Samoilova Yu.G., Sagan E.V. Oleinik O.A. [Metabolic imprinting in the development of obesity in children. In: Abstracts of the XVI All-Russian Seminar «Reproductive Potential of Russia: Versions and Counterversions»]. Sochi; 2022:115–116 (in Russian).
31. Ostrovskaya O.V., Nagovitsyna E.B., Vlasova M.A., Ivakhnishina N.M., Sidorchuk N.G. [Results of gene diagnostics of reproductively significant infections in pregnant women in Khabarovsk]. Dal'nevostochnyy meditsinskiy zhurnal 2017; 4:22–26 (in Russian).
32. Kozlov V.K., Pichugina S.V., Gandurov S.G., Evseeva G.P., Suprun S.V., Chaikа М.S., Lebed’ko O.A. [Clinical features of congenital stridor in children]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2023; 90:39–46 (in Russian). doi: 10.36604/1998-5029-2023-90-39-46
33. Baranova A.A., Namazova-Baranova L.S., Davydova I.V., editors. [Modern approaches to the prevention, diagnosis and treatment of bronchopulmonary dysplasia]. Moscow: Pediatr; 2013 (in Russian).
34. Pichugina S.V., Evseeva G.P., Suprun S.V., Sirotina-Karpova M.S., Kuznetsova M.S., Iakovlev E.I., Telepneva R.S., Kozlov V.K., Lebedko O.A. [Outcomes of bronchopulmonary dysplasia in children]. Amurskiy meditsinskiy zhurnal 2018; 24(4):14–17 (in Russian). doi: 10.22448/AMJ.2018.4.14-17
35. Kozlov V.K., Lebed’ko O.A., Morozova N.V., Pichugina S.V., Yakovlev E.I., Gandurov S.G., Evseeva G.P., Suprun S.V., Nagovitsyna E.B., Kuderova N.I. [Chronic bronchopulmonary diseases in children with bronchial obstruction syndrome]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2021; 82: 62–73 (in Russian). doi: 10.36604/1998-5029-2021-82-62-73
36. Bushmelev V.A., Sterkhova E.V. [Congenital lung malformations in the structure of chronic lung diseases in children (diagnosis and treatment)]. Prakticheskaya meditsina = Practical medicine 2008; 7(31):74–80 (in Russian).
37. Blinova S.A., Oripov F.S., Khamidova F.M. [Cellular and molecular mechanisms of pulmonary malformations]. Genes and Cells 2021; 16(1):24–28 (in Russian). doi: 10.23868/202104003
38. Andrade C.F., Ferreira H.P., Fischer G.B. Congenital lung malformations. J. Bras Pneumol. 2011; 37(2):259–71. doi: 10.1590/s1806-37132011000200017
39. Wong K.K.Y., Flake A.W., Tibboel D., Rottier R.J., Tam P.K.H. Congenital pulmonary airway malformation: advances and controversies. Lancet Child Adolesc. Health. 2018; 2:290–297. doi: 10.1016/S2352-4642(18)30035-X
40. Caldeira I., Fernandes-Silva H., Machado-Costa D., Correia-Pinto J., Moura R.S. Developmental pathways upderlying lung development and congenital lung disorders. Cells 2021; 10(11):2987. doi: 10.3390/cells10112987
41. Danopoulos S., Shiosaki J., Al Alam D. FGF signaling in lung development and disease: human versus mouse. Front. Genet. 2019; 10:170. doi: 10/3389/fgene.2019.00170
42. Swarr D.T., Peranteau W.H., Pogoriler J., Frank D.B., Scott Adzick N., Hedrick H.L., Morley M., Zhou S., Morrisey E.E. Novel molecular and phenotypic insights into congenital lung malformations. Am. J. Respir. Crit. Care Med. 2018; 197(10):1328–1339. doi: 10.1164/RCCM.201706-1243OC
43. Yakovlev E.I., Evseeva G.P., Pichugina S.V., Gandurov S.G., Knizhnikova E.V., Kozlov V.K., Suprun S.V., Galyant O.I., Rakitskaya E.V., Lebed’ko O.A. Epidemiological aspects of congenital malformations of the bronchopulmonary system in children of the Amur Region]. Bûlleten' fiziologiii patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2019; 74:70–77 (in Russian). doi: 10.36604/1998-5029-2019-74-70-77
44. Kurland G., Deterding R.R., Hagood J.S., Young L.R., Brody A.S., Castile R.G., Dell S., Fan L.L., Hamvas A., Hilman B.C., Langston C., Nogee L.M., Redding G.J. American Thoracic Society committee on childhood interstitial lung disease (chILD) and the chILD research Network. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am. J. Respir. Crit. Care Med. 2013; 188(3):376–394. doi: 10.1164/rccm.201305-0923ST
45. Deterding R.R. Children's interstitial and diffuse lung disease: progress and future horizons. Ann. Am. Thorac. Soc. 2015; 12:1451–1457. doi: 10.1513/AnnalsATS.201508-558PS
46. Boitsova E.V., Ovsyannikov D.Yu. [Оn the question of interstitial lung diseases in children: diffuse disorders of growth and development of the lungs]. Pediatr = Pediatrician (St. Petersburg) 2016; 7(2):104–112 (in Russian). doi: 10.17816/PED72104-112
47. Fan L.L., Dishop M.K., Galambos C., Askin F.B., White F.V., Langston C., Liptzin D.R., Kroehl M.E., Deutsch G.H., Young L.R., Kurland G., Hagood J., Dell S., Trapnell B.C., Deterding R.R. Children’s interstitial and diffuse lung disease research Network (chILDRN). Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the child classification scheme. Ann. Am. Thorac. Soc. 2015; 12(10):1498–1505. doi: 10.1513/AnnalsATS.201501-064OC
48. Lev N.S., Rozinova N.N., Shmelev E.I. [Interstitial lung diseases in children]. Russian Bulletin of Perinatology and Pediatrics 2014; 1:15–21 (in Russian).
49. Deutsch G.H., Young L.R., Deterding R.R., Fan L.L., Dell S.D., Bean J.A., Brody A.S., Nogee L.M., Trapnell B.C., Langston C., Pathology Cooperative Group, Albright E.A., Askin F.B., Baker P., Chou P.M., Cool C.M., Coventry S.C., Cutz E., Davis M.M., Dishop M.K., Galambos C., Patterson K., Travis W.D., Wert S.E., White F.V. Diffuse lung disease in young children: application of a novel classification scheme. Am. J. Respir. Crit. Care Med. 2007; 176(11):1120–1128. doi: 10.1164/rccm.200703-393OC
50. Saddi V., Beggs S., Bennetts B., Harrison J., Hime N., Kapur N., Lipsett J., Nogee L.M., Phu A., Suresh S., Schultz A., Selvadurai H., Sherrard S., Strachan R., Vyas J., Zurynski Y., Jaffé A. Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade's experience. Orphanet. J. Rare Dis. 2017; 12(1):133. doi: 10.1186/s13023-017-0637-x
51. Soares J.J., Deutsch G.H., Moore P.E., Fazili M.F., Austin E.D., Brown R.F., Sokolow A.G., Hilmes M.A., Young L.R. Childhood interstitial lung diseases: an 18-year retrospective analysis. Pediatrics 2013; 132(4):684–691. doi: 10.1542/peds.2013-1780
52. O'Reilly R., Kilner D., Ashworth M., Aurora P. Diffuse lung disease in infants less than 1 year old age: histopatological diagnoses and clinical outcome. Pediatr. Pulmonol. 2015; 50(10):1000–1008. doi: 10.1002/ppul.23124
53. Doan M.L., Guillerman R.P., Dishop M.K., Nogee L.M., Langston C., Mallory G.B., Sockrider M.M., Fan L.L. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008; 63(4):366–373. doi: 10.1136/thx.2007.083766
54. Wambach J.A., Casey A.M., Fishman M.P., Wegner S.E., Cole F.S., Hamvas A., Nogee L.M. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am. J. Respir. Crit. Care Med. 2014; 189:1538–1543. doi: 10.1164/rccm.201402-0342OC
55. Whitsett J.A., Kalin T.V., Xu Y. Kalinichenko V.V. Building and regenerating the lung cell by cell. Physiol. Rev. 2019; 99(1):513–554. doi: 10.1152/physrev.00001.2018
56. Deterding R.R., Deboer E.M., Cidon M.J., Robinson T.E., Warburton D., Deutsch J.H., Yong L.R. Approaching clinical trials in childhood intersticial lung disease and pediatric pulmonary fibrosis. Am. J. Respir. Crit Care Med. 2019; 200(10):1219–1227. doi: 10.1164/rccm.201903-0544CI
57. Bancalari E. [The newborn lung: neonatology questions and controversies]. Moscow: izdatel'stvo Logosfera; 2015 (in Russian).
58. Volkov I.K. [Chronic obstructive pulmonary disease – a pediatrician’s view]. Lechashchiy vrach = Lechaschi Vrach 2011; 8:78–85 (in Russian).
59. Röhl A., Baek S.H., Kachroo P., Morrow J.D., Tantisira K., Silverman E.K., Weiss S.T., Sharma A., Glass K., DeMeo D.L. Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease. Respir. Res. 2022; 23(1):69. doi: 10.1186/s12931-002-01963-5
60. Mizernitsky Yu.L. [Chronic lung diseases in children: evolution, realities, prospects. In: Mizernitsky Yu.L., editor. Pulmonology of childhood: problems and solutions]. Moscow: Medpraktika; 2018; 18:9–12 (in Russian).
61. Bogorad A.E., Diakova S.E., Mizernitsky Yu.L. [Primary ciliary dyskinesia: modern approaches to the diagnostics and treatment]. Russian Bulletin of Perinatology and Pediatrics 2019; 64(5):38–46 (in Russian). doi: 10.21508/1027–4065–2019–64–5–123–133
62. Rozinova N.N., Mizernitsky Yu.L. [Orphan lung diseases in children]. Moscow: Medpraktika; 2015 (in Russian).
63. Shapiro A.J., Zariwala M.A., Ferkol T., Davis S.D., Sagel S.D., Dell S.D., Rosenfeld M., Olivier K.N., Milla C., Daniel S.J., Kimple A.J., Manion M., Knowles M.R., Leigh M.Q. Diagnosis, monitoring and treatment of primary ciliare dyskinesia: PCD foundation consensus recommendations based on state of art review. Pediatr. Pulmonal. 2016; 51(2):115–132. doi: 10.1002/ppual.23304
64. Geppe N.A., Ozyorskaya I.V., Malyavina U.S., Tchokroborti G. [Effects of medications on ciliary epithelium in pediatric patients with viral respiratory infections]. Russian Medical Journal 2012; 24:1222–1227 (in Russian).
65. Kozlov V.K. [Health of children and adolescents in the Far East of Russia]. Khabarovsk: Dal'nevostochnyy gosudarstvennyy meditsinskiy universitet; 2020 (in Russian). ISBN: 978-5-85797-407-0.
Review
For citations:
Kozlov V.K. Chronic bronchopulmonary diseases in children: developmental characteristics and clinical course. Bulletin Physiology and Pathology of Respiration. 2025;(96):18-32. (In Russ.) https://doi.org/10.36604/1998-5029-2025-96-18-32